Sato Pharmaceutical
Manufacturing · 501-1,000 Employees
View Company Info for Free
Overview
Phone Number
+852 23677689Website
www.sato-seiyaku.co.jpRevenue
$37.6 MillionIndustry
About Sato Pharmaceutical
Sato Pharmaceutical Org Chart
Is Sato Pharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Sato Pharmaceutical is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Sato Pharmaceutical
Check if Sato Pharmaceutical has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Sato Pharmaceutical has new funding data
Product Launch: Get notified when Sato Pharmaceutical launches new products
Sato Pharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Sato Pharmaceutical had a recent Job posting/layoffs
Earning: See what the market has to say on Sato Pharmaceutical recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Sato Pharmaceutical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sato Pharmaceutical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sato Pharmaceutical.
Sato Pharmaceutical Tech Stack
A closer look at the technologies used by Sato Pharmaceutical
Most Recent Scoops
Sato Pharmaceutical News & Media
Novan Expands Nitric Oxide Dermatology Business Partnership with Sato in Japan
Expanded license agreement adds SB206 for the treatment of viral skin infections Novan to receive upfront cash consideration of approximately 1.25 billion JPY (~$11.0 million), payable over the next 12 months Milestone and royalty payments due with clinical, regulatory and commercial progression Japan, the world’s 2nd largest dermatology market, remains a strategic focus for Novan Novan continues to explore additional geographic markets and other business opportunities MORRISVILLE, N.C., Oct. 08Novan Expands Nitric Oxide Dermatology Business Partnership with Sato in Japan
MORRISVILLE, N.C., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company has expanded its partnership with Sato Pharmaceutical Co., Ltd. (“Sato”), a Japanese company with a prescription pharmaceutical business specializing in dermatology, to include Novan’s topical nitric oxide-releasing product candidate SB206 for the treatment of viral skin infections including warts and molluscum contagiosum.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sato Pharmaceutical
Sato Pharmaceutical Co., Ltd. is a pharmaceutical company focused on health and medicine. They offer a range of products including various health supplements and medications, such as the Yunker series and other health-related brands. Their intended clients include individuals seeking relief from health issues like gastric pain and nasal congestion.... Read More